Changes coming to weight loss drug coverage benefits, effective January 1, 2025 Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications
Common examples include insurance coverage changes, side effects, and availability
Researchers found these disparities by analyzing data from a 2022-23 federal, population-based survey on drug use, mental health, and behavioral health
It names dietary modification, structured physical activity, behavioural counselling, and close metabolic monitoring as safer interim approaches while nursing
How to buy semaglutide for sale during a shortage
Safety and Clinical Insights Introduction Finding the right rhythm for your weight loss journey often involves navigating the technical side of your medication